Articles by Emily Menendez
Patients with a complete resection at pcRPLND and <10% viable cells had favorable outcomes without any further treatment.
Bladder cancers that develop after radiation tend to be more aggressive and are more likely to be sarcomatoid variant.
Higher tumor fraction after chemohormonal therapy was also linked to aggressive pathologic features and poor outcomes.
The novel nomogram demonstrated perfect performance in discrimination ability and clinical net benefit.
AUA Amendment to Testicular Cancer Guideline Includes New Treatment Options, Imaging Recommendations
The AUA released a new amendment to their 2019 guideline for the diagnosis and treatment of early-stage testicular cancer.
The positive results were consistent with findings from the primary analysis, such as PFS and overall response benefit.
Black patients had a lower survival rate compared with White patients, and they experienced a sharp decline in survival.
Newly identified risk factors could be used in future studies on risk-adapted follow-up and treatment strategies.
The PNI is commonly used as a prognostic factor for malignant tumors, but its potential use for prostate cancer is unknown.
Utilizing BCR as a replacement measurement for OS in patients with localized prostate cancer is a controversial topic.
Improved PFS was associated with negative surgical margins and no 30-day surgical complications, plus pathologic downstaging.
Perioperative durvalumab with gemcitabine/cisplatin in patients with resectable MIBC resulted in high EFS and OS at 2 years.
Older patients over 70 years of age need improved care and management of UTUC to improve their outcomes.
A PSA decrease ≥30% after the first 2 cycles of 177Lu PSMA can serve as an early marker of response in clinical practice.
As mCRPC cells are deficient in retinoblastoma proteins, they have a hypersensitivity to taxanes such as cabazitaxel.
The second annual Uromigos: Live & Unplugged event will take place in Nashville, Tennessee, on November 3-4.
The trial’s 2 primary end points were PFS and overall survival, with a secondary end point of objective response rate.
Somatic alterations in DDR genes are common in patients with advanced urothelial cancer.
While nephrectomy is a common treatment for kidney cancer, it can result in loss of kidney function or kidney failure.
The SOLAR trial aimed to evaluate the safety and biodistribution of Copper Cu 64 PSMA I&T to detect prostate cancer.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.